GENEVA, Feb. 9 -- NOVARTIS AG (Lichtstrasse 354056 Basel) filed a patent application (PCT/IB2025/057651) for "COMPOSITIONS AND METHODS FOR THE TREATMENT OF LYSOSOMAL ACID LIPASE DEFICIENCY (LAL-D)" on Jul 28, 2025. With publication no. WO/2026/028089, the details related to the patent application was published on Feb 05, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): CHEN, Feng Graf (NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.250 MASSACHUSETTS AVENUECAMBRIDGE, Massachusetts 02139), FLYNN, Jonathan Robert (NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.250 MASSACHUSETTS AVENUECAMBRID...